Effect of polymorphism on IL1A to cancer susceptibility: Evidence based on 34,016 subjects by Haoran Xia, Yiding Chen, Jialin Meng, Chaozhao Liang

Get full text

TMSB10 drives prostate cancer aggressiveness via immune microenvironment regulation by Haoran Xia, Jiaxin Ning, Xiaoxiao Guo, Hongchen Song, Xuanhao Li, Xuan Wang

Get full text

Enzyme/pH-triggered anticancer drug delivery of chondroitin sulfate modified doxorubicin nanocrystal by Yan Liang, Xiaoheng Fu, Chen Du, Haoran Xia, Yusi Lai, Yong Sun

Get full text

A multi-scale local attention mechanism for aspect extraction by Qian Yang, Jinsen Zhu, Hongyu Du, Haoran Xia, Sisi Shao, Chen Yuan, Wengtao Wang, Yimu Ji

Get full text

Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA–IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial by Shuyu Ji, Zhenxin Sheng, Dongliang Bian, Minwei Bao, Kaiqi Jin, Wentian Zhang, Xinsheng Zhu, Fenghuan Sun, Haoran Xia, Han Zhang, Ziyun Shen, Huansha Yu, Lele Zhang, Jie Huang, Zhang Peng, Nan Song, Haifeng Wang, Biyun Qian, Yuming Zhu

Get full text